CoChat

Enhancing Outcomes from Major Depression: Using Antidepressant Combination Therapies with Multifunctional Pharmacologic Mechanisms from the Initiation of Treatment

Stahl, Stephen M. · 2010 · CNS Spectrums

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.

Abstract

Traditional guidelines call for treatment of major depression with a sequence of single antidepressants. Augmentation with a second agent generally only occurs when the first agent is well tolerated and when it also provides at least some symptomatic improvement on its own. Since this standard approach leads to low rates of attaining and sustaining remission by the first agent, with diminishing returns for each subsequent agent, there is growing dissatisfaction with this approach to the treatment of major depression. One new trend is to attempt to enhance the rates of sustained remission from a major depressive episode by combining two therapeutic agents from the very initiation of treatment of a major depressive episode. Traditional treatment of major depression begins with a single “first line” antidepressant, and if it does not work or is not tolerated, trying another and then another. Unfortunately, this strategy results in disappointing remission rates for the first antidepressant (Figure 1), and disappointing rates of maintaining any improvement that is attained by this first agent because of high relapse rates over the next year despite continuing treatment with the first antidepressant (Figure 2A). And that is the good news. The bad news is that with each subsequent antidepressant treatment administered remission rates are progressively reduced (Figure 1). For those patients who do improve, they are progressively less likely to sustain their therapeutic gains despite continuing to take the drug that led to their initial improvement (Figure 2).

Overview

Integrity signals

Registry

Crossref · 10.1017/s1092852900027334

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 56 references

Research works printed but not linked: 5

  1. Bares, 2009, Neuro Endocrinol Lett
  2. 10.1002/(SICI)1096-8628(19970919)74:5<526::AID-AJMG14>3.0.CO;2-E · DOI · Paper page
  3. Stahl, 2009, Stahls Essential Psychopharmacology Preserver's Guide
  4. 10.1177/026988110401800415 · doi:10.1177/026988110401800415
  5. Stahl, 2008, Stahls Essential Psychopharmacocology

Cited by

See all 40

Metadata

Authors
Stahl, S. M.
Affiliations
University of California San Diego (US)
Corresponding author
Stahl, Stephen M.
Venue
CNS Spectrums
Published
2010-02
Volume
15
Issue
2
Pages
79-94
ISSN
  • 1092-8529 (ISSN-L)
  • 2165-6509
OpenAlex
W2461699656
Cited by
40
References
56
Citations by year
2024: 3 · 2022: 1 · 2021: 1 · 2019: 1 · 2018: 5 · 2016: 1 · 2015: 5 · 2014: 7 · 2013: 6 · 2012: 6
FWCI
3.77
Type
journal article
Language
en
Open access
closed
Locations
  • CNS Spectrums (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
Keywords
major depressive disorder, antidepressant combination therapy, augmentation therapy, first-line antidepressants, remission rate, relapse, sustained remission, treatment-resistant depression
MeSH terms
Antidepressive Agents, Depressive Disorder, Major, Major Depressive Disorder, Drug Therapy, Combination, Humans, Models, Biological, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Enhancing Outcomes from Major Depression: Using Antidepressant Combination Therapies with Multifunctional Pharmacologic Mechanisms from the Initiation of Treatment. https://app.cochat.ai/papers/10.1017/s1092852900027334
The paper
Stahl, S. M. (2010). Enhancing Outcomes from Major Depression: Using Antidepressant Combination Therapies with Multifunctional Pharmacologic Mechanisms from the Initiation of Treatment. CNS Spectrums. https://doi.org/10.1017/s1092852900027334

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.